Lululemon Is Down 57% in 2025. Is This a Once-in-a-Lifetime Buying Opportunity Before the Stock Goes Parabolic?

Lululemon's stock has declined nearly 57% in 2025, significantly underperforming the S&P 500, driven by decelerating top-line growth, peaking gross margins, and slowing North American sales. While the company projects reaching its 'Power of Three x2' revenue goal of $12.5 billion by fiscal 2026, analysts anticipate much lower growth and an 11-13% EPS decline for the current year, creating a notable divergence in outlook. Despite trading at 12 times next year's earnings, this discount reflects the market's skepticism regarding Lululemon's ability to navigate macroeconomic and competitive headwinds, suggesting a cautious stance until clearer positive catalysts emerge.

Analysis

Lululemon's stock has sharply underperformed, declining nearly 57% in 2025 against a 13% rise in the S&P 500, reflecting significant fundamental deterioration. The company's growth is decelerating rapidly, with year-over-year revenue growth slowing from 30% in fiscal 2022 to just 7% in the first half of fiscal 2025, and comparable sales growth collapsing from 16% to 1% over the same period. This slowdown is primarily driven by weakening performance in its largest market, North America, amid macroeconomic and competitive pressures. Gross margins appear to have peaked at 59.2% in fiscal 2024 and are now contracting as the company relies more on markdowns. A significant point of concern is the divergence between management's guidance and market expectations; while the company projects a full-year EPS decline of 11-13%, it maintains its ambitious "Power of Three x2" goal of reaching $12.5 billion in revenue by fiscal 2026, which would require a sharp re-acceleration. Analysts, however, remain skeptical, forecasting revenue of only $11.5 billion for fiscal 2026. The abrupt resignation of the Chief Product Officer further clouds the outlook, making the stock's seemingly cheap valuation of 12 times forward earnings appear warranted given the heightened execution risk.

Key Decisions for Investors

• Investors should treat the current valuation of 12 times forward earnings with caution, as it may represent a value trap given the company's projection of an 11-13% EPS decline for the current fiscal year.
• Monitor comparable sales growth in North America and gross margin trends for any signs of stabilization, as these are the key 'green shoots' required before considering the stock as a viable turnaround play.
• Critically assess the credibility of management's long-term 'Power of Three x2' revenue target against the more bearish analyst consensus, as the significant gap in expectations represents the primary source of risk and potential reward for the stock.